Right Ventricular Longitudinal Strain Reproducibility Using Vendor-Dependent and Vendor-Independent Software - 02/06/18

Abstract |
Background |
Right ventricular peak systolic longitudinal strain (RVLS) has emerged as an approach for quantifying right ventricular function in diseases such as pulmonary hypertension and congenital heart disease. A major limitation in applying RVLS is that strain imaging and analysis are proprietary, which may result in systematic differences from vendor to vendor. The goal of this study was to test the reproducibility of right ventricular strain analysis among selected vendor-specific software (VSS) and vendor-independent software (VIS) on images obtained from different ultrasound scanners, as would be common in clinical practice or in a multicenter clinical trial.
Methods |
In this prospective, single-center study, 35 patients (5 healthy subjects and 30 with pulmonary hypertension) each underwent two echocardiographic scans, one using GE (Vivid E9) and the other using Philips (iE33) ultrasound systems. Images were analyzed using both VSS and VIS (TomTec) software for determination of RVLS. A repeated-measures analysis of variance was used to assess for any systematic differences among methods, as well as effects of scanner and software and a possible interaction between scanner and software for each strain measurement.
Results |
Differences for global strains were not statistically significant among VSS packages (P ≥ .05), but some differences were noted between VSS and VIS. Wide variability between regional peak strain measurements was noted, but no systematic differences were found.
Conclusions |
Global RVLS values between VSS systems are not significantly different but may differ slightly from VIS. When comparing regional strain between VSS and VIS analyses, there is widespread variability without clear systematic differences.
Le texte complet de cet article est disponible en PDF.Highlights |
• | RVLS is a novel assessment of RV function. |
• | There is little information on agreement on RVLS derived from different platforms. |
• | We found no major systematic differences with vendor-specific imaging or algorithms. |
• | Variability was acceptable (∼10%) for global but high (∼30%) for regional RVLS. |
• | Global RVLS has good reproducibility for future clinical and research applications. |
Keywords : Right ventricular strain, Echocardiography, Reproducibility, Validation
Abbreviations : CoV, DICOM, LoL, LV, PH, RV, RVLS, SDb, VIS, VSS
Plan
| This study was funded as an investigator-initiated study to Drs. Rajagopal and Samad from Gilead Sciences. Dr. Kisslo is a speaker for Philips and GE and holds grants from Medtronic, Philips, and Novaseed. Dr. Rajagopal has received research support from the National Institutes of Health (grant K08HL114643), a Burroughs Wellcome Career Award for Medical Scientists, Actelion, and United Therapeutics and has received consulting fees and honoraria from Actelion, United Therapeutics, and Gilead Sciences. Dr. Velazquez has received research support from the National Heart, Lung, and Blood Institute, Novartis, Amgen, Pfizer, Alnylam, Bay Labs, Philips, and GE and has received consulting fees and honoraria from Novartis, Amgen, Philips, Merck, Abiomed, and Expert Exchange. Dr. Velazquez is supported by grants R01 HL105853, R01 HL118077, U10 HL084904, and U01 HL125511 from the National Institutes of Health. |
|
| Conflicts of Interest: None. |
Vol 31 - N° 6
P. 721 - juin 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
